Granzyme B Deficiency Protects Against Angiotensin II-induced Cardiac Fibrosis via a Perforin-independent Mechanism

Yue Shen,Fang Cheng,Mehul Sharma,Yulia Merkulova,Sheetal A. Raithatha,Leigh G. Parkinson,Hongyan Zhao,Kathryn Westendori,Lubos Bohunek,Tatjana Bozin,Ivy Hsu,Lisa S. Ang,Sarah J. Williams,R. C. Bleackley,John E. Eriksson,Michael A. Seidman,Bruce M. McManus,David J. Granville
DOI: https://doi.org/10.1161/circ.132.suppl_3.11078
IF: 37.8
2015-01-01
Circulation
Abstract:Introduction: Granzyme B (GzmB) is a serine protease involved in immune cell-mediated apoptosis that is enabled through a mechanism involving the pore-forming protein, perforin that facilitates internalization. However, recent evidence suggests that GzmB contributes to matrix remodeling and fibrosis through an extracellular, perforin-independent process. Hypothesis: GzmB contributes to cardiac fibrosis through a perforin-independent pathway involving extracellular proteolysis. Methods: Using a murine model of Angiotensin II (Ang II)-induced cardiac fibrosis, wild-type, GzmB deficient and Perforin deficient mice were treated with Ang II for 4 weeks, and were examined for the presence of cardiac fibrosis. Echocardiography was performed in these mice to examine the cardiac function. The level of Inflammation and inflammatory cells infiltration were examined by immunohistochemistry and RT-PCR analysis. The in vitro endothelial barrier function was measured by electric cell-substrate impedance sensing. Results...
What problem does this paper attempt to address?